Request Demo
Last update 20 Feb 2025
Shenzhen Sanofi Pasteur Biological Products Co. Ltd.
Joint Venture Company | Subsidiary Company|
1996|
Guangdong Sheng, China
Last update 20 Feb 2025
Overview
Tags
Infectious Diseases
Other Diseases
Respiratory Diseases
Prophylactic vaccine
Toxoid vaccine
Combination vaccine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20242605
一项旨在评估呼吸道合胞病毒疫苗在婴幼儿中的效力、免疫原性和安全性的 III 期、随机、观察者设盲、安慰剂对照、多中心、多国研究 (PEARL)
[Translation] A Phase III, randomized, observer-blinded, placebo-controlled, multicenter, multinational study to evaluate the efficacy, immunogenicity, and safety of respiratory syncytial virus vaccines in infants and young children (PEARL)
CTR20231927
一项在中国健康青少年、儿童、幼儿和婴儿中开展的研究性四价脑膜炎球菌结合疫苗的开放标签、年龄递减的安全性和免疫原性 I 期研究
[Translation] An open-label, age-decreased, phase I study of the safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine in healthy adolescents, children, toddlers, and infants in China
CTR20191860
在中国 40名健康成年受试者中的I期、开放、单组、单中心的评估肌肉注射Flublok四价流感疫苗的安全性研究
[Translation] A Phase I, open-label, single-group, single-center study evaluating the safety of intramuscular Flublok quadrivalent influenza vaccine in 40 healthy adult subjects in China
100 Clinical Results associated with Shenzhen Sanofi Pasteur Biological Products Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shenzhen Sanofi Pasteur Biological Products Co. Ltd.
Login to view more data
100 Translational Medicine associated with Shenzhen Sanofi Pasteur Biological Products Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 21 Feb 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
1
Phase 3
Approved
2
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free